Daslemia 50 mg Tablet
$42.44
$34.62
Daslemia 50 mg tablet is an innovative anti-cancer treatment that features dasatinib as its active component, specifically designed for managing certain malignancies. This medication is primarily utilized in the treatment of chronic myeloid leukemia (CML), a blood cancer characterized by the uncontrolled production of white blood cells. Dasatinib works by inhibiting specific proteins that promote cancer cell growth, thereby helping to restore balance in the body. Patients taking Daslemia should be aware of potential side effects, including but not limited to low blood cell counts and fluid retention, which necessitate regular monitoring by healthcare professionals. As with any cancer therapy, it’s crucial to discuss your complete medical history with your doctor before starting treatment to ensure it is safe and effective for you. By targeting the underlying mechanisms of CML, Daslemia aims to improve patient outcomes and quality of life. Always follow your physician's instructions regarding dosage and administration to maximize the benefits of this medication.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Daslemia 50 mg tablet is primarily utilized in the management of chronic myeloid leukemia (CML). This condition is a type of cancer that disrupts normal blood and bone marrow function. Patients may experience symptoms such as fatigue, weakness, and an enlarged spleen. The medication helps to control the progression of the disease and improve overall quality of life.
• In addition to CML, Daslemia 50 mg tablet is also indicated for the treatment of acute lymphoblastic leukemia (ALL). This aggressive form of leukemia affects the white blood cells and can lead to severe symptoms, including shortness of breath and frequent infections. By using Daslemia 50 mg tablet, healthcare providers aim to target the underlying causes of ALL, helping to manage symptoms effectively. This therapeutic approach supports patients during their treatment journey.
• Daslemia 50 mg tablet serves as an essential component in the treatment regimens for both CML and ALL. Its mechanism of action helps to inhibit specific pathways involved in the proliferation of cancer cells. By addressing these pathways, Daslemia 50 mg tablet not only alleviates symptoms but also aims to slow down disease progression. This makes it a valuable option for oncologists when formulating treatment plans for affected patients.
Benefits
Daslemia 50 mg Tablet is effective and has a high rate of response in people with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia. It decreases the number of cancer cells in the blood and bone marrow and improves blood counts in people with CML or ALL. Daslemia 50 mg Strip is usually taken once a day, which may be more convenient for some people compared to other treatments. Daslemia 50 mg is effective in people with CML or ALL who have not responded to other treatments.
Side Effects
Anti-cancer Drug Daslemia may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Fever
• Nausea
• Vomiting
• Bleeding
• Skin rash
• Diarrhoea
• Infection
• Bone marrow suppression
• Pleural effusion
• Abdominal pain
Common Side Effects
• Difficulty breathing
• Headache
• Tiredness
• Fatigue
• Muscle and joint pain
• Swelling in the hands and feet
How To Use
Dasatinib Tablet 50 mg may be taken with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Daslemia 50 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Daslemia 50 mg Tablet and report any unusual symptoms or changes in kidney function to their physician. The dose of Daslemia 50 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Daslemia 50 mg Strip. Daslemia 50 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Anti-cancer Drug Daslemia, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Daslemia 50 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Daslemia 50 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Dasatinib Tablet 50 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Daslemia 50 mg may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Anti-cancer Drug Daslemia during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Daslemia 50 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Daslemia Tablet.